Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22809449 | 0.90 | SCN9A (0.50) | SCN9ALMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL22809637 | 0.86 | ALDH1A1 (0.51) | SCN9ALMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL13197550 | 0.73 | CYP1A2 (0.52) | SCN9ALMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL16592086 | 0.72 | SMN1; SMN2 (0.52) | LMNASMN1; SMN2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL22809604 | 0.71 | CYP1A2 (0.48) | LMNASMN1; SMN2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL22809573 | 0.71 | SCN9A (0.42) | SCN9ALMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL19083678 | 0.70 | CYP1A2 (0.46) | LMNASMN1; SMN2ALDH1A1HPGDCYP1A2 | |
| SCHEMBL16592103 | 0.70 | CYP1A2 (0.52) | SCN9ALMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL19664461 | 0.70 | SMN1; SMN2 (0.53) | SCN9ALMNASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL14051590 | 0.69 | CYP1A2 (0.55) | LMNASMN1; SMN2ALDH1A1HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3487839-B1 | AMIDE DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS | RAQUALIA PHARMA INC (JP) | 2020-12-23 | — | — | EP | disclosed |